Financials
- Market Capitalization 3.55 B
- Employee 10 K
- Founded N/A
- CEO N/A
- Website www.organon.com
- Headquarter New Jersey, United States
- FIGI BBG00ZQRGW24
- Industry Fabricants de Médicaments — Généralités
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
9.96
ratio cours/chiffre d'affaires
0.3
Dividende par action
0.34
Rendement du dividende (%)
4.74
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1302 | ORKA Oruka Therapeutics, Inc. - Common Stock | 87.47 USD | +3.44% | +3.51% | +26.68% | +172.75% | 5.28 B USD | ||
| 1396 | MANE Veradermics, Incorporated Common Stock | 109.89 USD | -0.10% | -5.75% | +14.88% | +233.00% | 4.59 B USD | ||
| 1797 | MBX MBX Biosciences, Inc. - Common Stock | 56.59 USD | -5.75% | -9.22% | +43.81% | +304.21% | 2.69 B USD | ||
| 1930 | PVLA Palvella Therapeutics, Inc. - Common Stock | 149.68 USD | +2.50% | +5.18% | +27.93% | +102.68% | 2.15 B USD |